LINC02766

Across TCGA pan-cancer cohorts, LINC02766 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC02766 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC02766 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02766 expression acts as an unfavorable survival marker, although some lineages such as HNSC and THCA show a favorable association.

HNSC, THCA, and BLCA are the cancer types where LINC02766 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Quartile	III,IV	0.488	0.296	.003	80	view →
THCA	OS	Tertile	III,IV	1.000	0.746	.005	61	view →
BLCA	OS	Quartile	II,III,IV	0.789	0.663	.004	31	view →
ACC	DFS	Median	IV	0.472	0.089	.012	21	view →
READ	DFS	Tertile	IV	0.290	0.736	.004	21	view →
SARC	OS	Quartile	All	0.821	0.652	.004	19	view →
PAAD	DFS	Tertile	II,III,IV	0.545	0.357	.009	18	view →
LUAD	OS	Median	All	0.452	0.268	.013	7	view →
CHOL	DFS	Tertile	IV	0.356	0.834	.038	6	view →
UCEC	DFS	Median	II,III,IV	0.783	0.858	.030	4	view →
COAD	DFS	Tertile	All	0.696	0.813	.023	3	view →
ESCA	DFS	Median	II,III,IV	0.393	0.222	.028	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC02766–HNSC (DFS)

Open the HNSC breakdown →